Zimmer Biomet Holdings Americas — Goodwill Impaired Accumulated Impairment Loss remained flat by 0.0% to $7.70M in Q1 2026 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
An increase indicates that past acquisitions in the region are underperforming or facing market headwinds.
The cumulative total of impairment charges recognized against goodwill within the Americas segment. This reflects manage...
Commonly monitored by investors to assess the success of historical inorganic growth strategies.
zbh_segment_americas_goodwill_impaired_accumulated_impairment_loss| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $7.70M | $7.70M | $7.70M | $7.70M | $7.70M | $7.70M | $7.70M | $7.70M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | +0.0% | +0.0% | +0.0% | — | — | +0.0% | — |